BIOSTOCK : CombiGene comments on their latest progress
MarketScreener,
Last week, reported that the company's two warrants were exercised at 98.4 percent, which thus added just over SEK 25 million…
Last week, reported that the company's two warrants were exercised at 98.4 percent, which thus added just over SEK 25 million…
Associate Professor David Woldbye, one of CombiGene’s scientific founders, presents in a new peer-reviewed article in Frontiers…